Effects of glepaglutide, a long-acting glucagon-like peptide-2 analog, on intestinal morphology and perfusion in patients with short bowel syndrome: Findings from a randomized phase 2 trial.

JPEN J Parenter Enteral Nutr · 2023 · PMC10084040 · PMID 35511704

Europe PMC DOI

hedged sentence

0.4270

closest p · 8.5× alpha

0.4270

boldest claim

The sentences

did not reach statistical significanceP = 0.427not close (p > 0.1)

The numerical increase in villus height of 84 μm in the 10 mg dose group, however, did not reach statistical significance ( P = 0.427).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.